Surgepays Historical Cash Flow

SURG Stock  USD 1.92  0.19  9.00%   
Analysis of Surgepays cash flow over time is an excellent tool to project Surgepays future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Total Cash From Operating Activities of 10.8 M or Net Income of 21.6 M as it is a great indicator of Surgepays ability to facilitate future growth, repay debt on time or pay out dividends.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Surgepays latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Surgepays is a good buy for the upcoming year.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.

About Surgepays Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Surgepays balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Surgepays's non-liquid assets can be easily converted into cash.

Surgepays Cash Flow Chart

At this time, Surgepays' Other Non Cash Items is most likely to increase significantly in the upcoming years. The Surgepays' current Capital Expenditures is estimated to increase to about 295.4 K, while Total Cash From Financing Activities is forecasted to increase to (2.3 M).

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Surgepays' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Other Non Cash Items is most likely to increase significantly in the upcoming years. The Surgepays' current Capital Expenditures is estimated to increase to about 295.4 K, while Total Cash From Financing Activities is forecasted to increase to (2.3 M).
 2021 2022 2023 2024 (projected)
Begin Period Cash Flow674.0K6.3M7.0M7.4M
End Period Cash Flow6.3M7.0M14.6M15.4M

Surgepays cash flow statement Correlations

0.35-0.520.040.270.640.940.740.130.570.65-0.130.1-0.170.310.73-0.780.220.19-0.83-0.83-0.83
0.35-0.430.060.260.920.520.630.470.740.130.320.12-0.04-0.290.67-0.16-0.63-0.77-0.7-0.7-0.7
-0.52-0.43-0.83-0.86-0.54-0.75-0.90.42-0.35-0.510.65-0.20.82-0.13-0.890.740.140.240.480.480.48
0.040.06-0.830.790.040.30.53-0.75-0.110.35-0.760.03-0.950.10.53-0.51-0.13-0.160.010.010.01
0.270.26-0.860.790.330.550.77-0.420.250.42-0.720.15-0.820.260.71-0.53-0.05-0.28-0.31-0.31-0.31
0.640.92-0.540.040.330.750.770.430.810.230.160.28-0.07-0.20.8-0.37-0.42-0.52-0.85-0.85-0.85
0.940.52-0.750.30.550.750.930.040.640.7-0.260.11-0.40.30.92-0.830.06-0.07-0.86-0.86-0.86
0.740.63-0.90.530.770.770.93-0.060.640.65-0.370.11-0.590.250.98-0.76-0.11-0.33-0.78-0.78-0.78
0.130.470.42-0.75-0.420.430.04-0.060.62-0.170.65-0.020.73-0.03-0.010.45-0.28-0.4-0.42-0.42-0.42
0.570.74-0.35-0.110.250.810.640.640.620.280.130.080.10.160.67-0.19-0.26-0.52-0.79-0.79-0.79
0.650.13-0.510.350.420.230.70.65-0.170.28-0.23-0.42-0.440.720.62-0.80.330.0-0.51-0.51-0.51
-0.130.320.65-0.76-0.720.16-0.26-0.370.650.13-0.23-0.230.74-0.32-0.360.39-0.23-0.24-0.08-0.08-0.08
0.10.12-0.20.030.150.280.110.11-0.020.08-0.42-0.23-0.07-0.470.130.040.090.1-0.09-0.09-0.09
-0.17-0.040.82-0.95-0.82-0.07-0.4-0.590.730.1-0.440.74-0.07-0.16-0.560.60.00.040.070.070.07
0.31-0.29-0.130.10.26-0.20.30.25-0.030.160.72-0.32-0.47-0.160.21-0.360.540.1-0.16-0.16-0.16
0.730.67-0.890.530.710.80.920.98-0.010.670.62-0.360.13-0.560.21-0.72-0.18-0.38-0.79-0.79-0.79
-0.78-0.160.74-0.51-0.53-0.37-0.83-0.760.45-0.19-0.80.390.040.6-0.36-0.72-0.32-0.20.520.520.52
0.22-0.630.14-0.13-0.05-0.420.06-0.11-0.28-0.260.33-0.230.090.00.54-0.18-0.320.650.120.120.12
0.19-0.770.24-0.16-0.28-0.52-0.07-0.33-0.4-0.520.0-0.240.10.040.1-0.38-0.20.650.270.270.27
-0.83-0.70.480.01-0.31-0.85-0.86-0.78-0.42-0.79-0.51-0.08-0.090.07-0.16-0.790.520.120.271.01.0
-0.83-0.70.480.01-0.31-0.85-0.86-0.78-0.42-0.79-0.51-0.08-0.090.07-0.16-0.790.520.120.271.01.0
-0.83-0.70.480.01-0.31-0.85-0.86-0.78-0.42-0.79-0.51-0.08-0.090.07-0.16-0.790.520.120.271.01.0
Click cells to compare fundamentals

Surgepays Account Relationship Matchups

Surgepays cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash(98.6K)328.0K5.6M752.2K7.6M8.0M
Free Cash Flow(6.8M)(4.3M)(15.3M)94.7K10.0M10.5M
Change In Working Capital(152.5K)3.9M(2.7M)(25.9M)(13.9M)(13.2M)
Other Non Cash Items505.2K(628.2K)2.2M26.1M1.9M2.7M
Capital Expenditures227.6K6.6K51.4K698.6K281.3K295.4K
Total Cash From Operating Activities(6.5M)(4.3M)(15.3M)793.3K10.3M10.8M
Net Income(8.4M)(10.7M)(13.5M)(553.2K)20.6M21.6M
Total Cash From Financing Activities6.5M4.6M21.3M1.5M(2.4M)(2.3M)
End Period Cash Flow346.0K674.0K6.3M7.0M14.6M15.4M
Begin Period Cash Flow444.6K346.0K674.0K6.3M7.0M7.4M
Other Cashflows From Financing Activities4.2M10.0M(2.2M)(1.5M)(810.1K)(769.6K)
Change To Inventory2.1M(178.3K)(4.3M)(6.9M)2.1M2.2M
Stock Based Compensation329.6K183.0K3.6K140.7K529.5K556.0K
Depreciation282.9K1.4M917.5K988.7K1.1M1.2M
Change To Account Receivables(3.6M)1.1M(3.1M)(5.9M)(395.7K)(415.5K)
Total Cashflows From Investing Activities(32.2K)8.4K(376.7K)(1.5M)(1.3M)(1.3M)
Investments(32.2K)15.0K(376.7K)(1.5M)(281.3K)(295.4K)
Net Borrowings3.3M4.1M2.2M1.5M1.7M1.5M
Change To Operating Activities1.2M(167.2K)(86.5K)12.9M14.8M15.5M
Change To Liabilities1.4M2.8M4.6M121.1K139.3K132.3K

Currently Active Assets on Macroaxis

When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.78)
Earnings Share
(1.18)
Revenue Per Share
6.864
Quarterly Revenue Growth
(0.58)
Return On Assets
(0.02)
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.